A detailed history of Ostrum Asset Management transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Ostrum Asset Management holds 1,924 shares of CRL stock, worth $379,008. This represents 0.03% of its overall portfolio holdings.

Number of Shares
1,924
Previous 2,075 7.28%
Holding current value
$379,008
Previous $562 Million 29.31%
% of portfolio
0.03%
Previous 0.04%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$206.39 - $268.73 $31,164 - $40,578
-151 Reduced 7.28%
1,924 $397 Million
Q4 2023

Feb 13, 2024

BUY
$164.52 - $238.84 $1,480 - $2,149
9 Added 0.44%
2,075 $491 Million
Q3 2023

Nov 14, 2023

SELL
$194.44 - $217.61 $2,722 - $3,046
-14 Reduced 0.67%
2,066 $405 Million
Q2 2023

Aug 11, 2023

BUY
$183.71 - $210.25 $551 - $630
3 Added 0.14%
2,080 $437 Million
Q1 2023

May 12, 2023

BUY
$191.89 - $259.92 $398,555 - $539,853
2,077 New
2,077 $419 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Ostrum Asset Management Portfolio

Follow Ostrum Asset Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ostrum Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Ostrum Asset Management with notifications on news.